Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,724 | -48,471 | -38,958 | -18,010 | -113,293 |
| Depreciation Amortization | 16,256 | 3,357 | 2,054 | 1,744 | 4,732 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -486 |
| Accounts receivable | -1,332 | -2,529 | -735 | -774 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 9,928 |
| Other Working Capital | -7,766 | 1,787 | -3,037 | -20 | -3,021 |
| Other Operating Activity | 5,899 | 7,141 | 3,978 | 1,679 | 19,978 |
| Operating Cash Flow | $-34,667 | $-38,715 | $-36,698 | $-15,381 | $-82,162 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -31,779 | -77,428 | N/A | N/A | -174,271 |
| PPE Investments | -1,964 | -4,468 | -1,854 | -204 | -3,537 |
| Net Acquisitions | N/A | N/A | -13,186 | N/A | N/A |
| Sale Of Investment | 27,999 | 64,445 | N/A | N/A | 159,622 |
| Other Investing Activity | 0 | -556 | 0 | 0 | 0 |
| Investing Cash Flow | $-5,744 | $-18,007 | $-15,040 | $-204 | $-18,186 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,761 | 14,872 | N/A | N/A |
| Debt Repayment | -15,092 | -15,079 | -5,081 | -107 | N/A |
| Common Stock Issued | 8,247 | 580 | 112,657 | 11 | 130,720 |
| Other Financing Activity | 18,410 | -752 | -1,367 | 0 | -1,066 |
| Financing Cash Flow | $11,565 | $4,510 | $121,081 | $-96 | $129,654 |
| Exchange Rate Effect | -3 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 30,594 | 82,806 | 13,463 | 29,144 | 56,224 |
| End Cash Position | 1,745 | 30,594 | 82,806 | 13,463 | 85,530 |
| Net Cash Flow | $-28,849 | $-52,212 | $69,343 | $-15,681 | $29,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,667 | -38,715 | -36,698 | -15,381 | -82,162 |
| Capital Expenditure | -1,980 | -4,468 | -1,854 | -204 | -3,537 |
| Free Cash Flow | -36,647 | -43,183 | -38,552 | -15,585 | -85,699 |